Search research articles
Contact Us
Filters
Showing results (21-30 of 360) with videos related to
Page
of 36
Sort By:
CNS Neuroscience & Therapeutics
|
June 22, 2010
The role of dopamine in symptoms and treatment of apathy in Alzheimer's disease
Robert A Mitchell, Nathan Herrmann, Krista L Lanctôt
The Journal of Neuropsychiatry and Clinical Neurosciences
|
September 21, 2004
The role of norepinephrine in the behavioral and psychological symptoms of dementia
Nathan Herrmann, Krista L Lanctôt, Lyla R Khan
Journal of Geriatric Psychiatry and Neurology
|
April 5, 2011
Validity and responsiveness to change of clinically derived MDS scales in Alzheimer disease outcomes research
Kelly A Smart, Nathan Herrmann, Krista L Lanctôt
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
November 1, 1989
Benzodiazepine use and abuse in Canada
U Busto, K L Lanctôt, P Isaac, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
May 9, 2013
Assessing the validity of a computer-generated cognitive screening instrument for patients with multiple sclerosis
Helen Lapshin, Krista L Lanctôt, Paul O'Connor, et al.
Journal of Clinical Pharmacology
|
February 1, 1993
Comparative study on benzodiazepine use in Canada and Chile
I Ruiz, J Offermanns, K L Lanctôt, et al.
The Journal of Clinical Psychiatry
|
December 10, 2015
Cholinesterase inhibitor discontinuation in patients with Alzheimer's disease: a meta-analysis of randomized controlled trials
Jordana O'Regan, Krista L Lanctôt, Graham Mazereeuw, et al.
The European Journal of Neuroscience
|
May 12, 2017
The effect of acute exercise on blood concentrations of brain-derived neurotrophic factor in healthy adults: a meta-analysis
Adam Dinoff, Nathan Herrmann, Walter Swardfager, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
|
July 16, 2015
Risk Factors for Progression of Alzheimer Disease in a Canadian Population: The Canadian Outcomes Study in Dementia (COSID)
Nathan Herrmann, Tetsuhiro Harimoto, Robert Balshaw, et al.
Journal of Clinical Pharmacology
|
October 1, 1992
Advances in the diagnosis of adverse drug reactions
C A Naranjo, N H Shear, K L Lanctôt
Page
of 36
Search research articles
Search
Showing results (21-30 of 360) with videos related to
Sort By:
Page
of 36
CNS Neuroscience & Therapeutics
|
June 22, 2010
The role of dopamine in symptoms and treatment of apathy in Alzheimer's disease
Robert A Mitchell, Nathan Herrmann, Krista L Lanctôt
The Journal of Neuropsychiatry and Clinical Neurosciences
|
September 21, 2004
The role of norepinephrine in the behavioral and psychological symptoms of dementia
Nathan Herrmann, Krista L Lanctôt, Lyla R Khan
Journal of Geriatric Psychiatry and Neurology
|
April 5, 2011
Validity and responsiveness to change of clinically derived MDS scales in Alzheimer disease outcomes research
Kelly A Smart, Nathan Herrmann, Krista L Lanctôt
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
November 1, 1989
Benzodiazepine use and abuse in Canada
U Busto, K L Lanctôt, P Isaac, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
May 9, 2013
Assessing the validity of a computer-generated cognitive screening instrument for patients with multiple sclerosis
Helen Lapshin, Krista L Lanctôt, Paul O'Connor, et al.
Journal of Clinical Pharmacology
|
February 1, 1993
Comparative study on benzodiazepine use in Canada and Chile
I Ruiz, J Offermanns, K L Lanctôt, et al.
The Journal of Clinical Psychiatry
|
December 10, 2015
Cholinesterase inhibitor discontinuation in patients with Alzheimer's disease: a meta-analysis of randomized controlled trials
Jordana O'Regan, Krista L Lanctôt, Graham Mazereeuw, et al.
The European Journal of Neuroscience
|
May 12, 2017
The effect of acute exercise on blood concentrations of brain-derived neurotrophic factor in healthy adults: a meta-analysis
Adam Dinoff, Nathan Herrmann, Walter Swardfager, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
|
July 16, 2015
Risk Factors for Progression of Alzheimer Disease in a Canadian Population: The Canadian Outcomes Study in Dementia (COSID)
Nathan Herrmann, Tetsuhiro Harimoto, Robert Balshaw, et al.
Journal of Clinical Pharmacology
|
October 1, 1992
Advances in the diagnosis of adverse drug reactions
C A Naranjo, N H Shear, K L Lanctôt
Page
of 36